Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Subtitle:
Article type: Research Article
Authors: Masood, Nosheen* | Mubashar, Aroosha | Yasmin, Azra
Affiliations: Department of Environmental Sciences, Fatima Jinnah Women University, The Mall, Rawalpindi, Pakistan
Correspondence: [*] Corresponding author: Nosheen Masood, Department of Environmental Sciences, Fatima Jinnah Women University, The Mall, Rawalpindi, Pakistan. Tel.: +92 334 5890589; E-mail:nosheenmasood@hotmail.com
Abstract: BACKGROUND: GSTM1 and GSTT1 are phase II enzymes which provide chemical defense to cells. OBJECTIVE: This study was designed to evaluate association of GSTM1 and GSTT1 deletion along with epidemiological factors with risk of colon and rectum cancers. METHODOLOGY: Multiplex PCR was used for cancer patients as well as age and gender matched cancer free controls. RESULTS: Mean age of patients and controls was 45.5 (± 14.6) and 43.5 (± 18.08) years respectively. Among epidemiological factors; gender, age ≥ 50 years, active/passive smoking, naswar addiction, residential area, family history, red meat, fruit and vegetable intake showed no association with CRC (P ≥ 0.05). Symptoms of CRC like altered bowel habits (70%) was more common compared with other symptoms. GSTM1 (P ≤ 0.05) and GSTT1 (P ≤ 0.05) deletions were found to be significantly associated with CRC compared with controls. Association of epidemiological factors like gender, active/passive smoking, naswar addiction, residential area and family history were associated neither with GSTM1 deletion nor to GSTT1 deletion in both cancers (P ≥ 0.05). Significant association was present between stage III and GSTM1 (CI 95% 0.15-1.39) as well as GSTT1 (CI 95% 0.14-2.44) deletion in CRC. CONCLUSION: These results suggest that GSTM1 and GSTT1 deletion were associated with increased risk of colon and rectum cancer in Pakistani population.
Keywords: GSTM1, GSTT1, epidemiology, colon cancer, rectum cancer
DOI: 10.3233/CBM-150498
Journal: Cancer Biomarkers, vol. 15, no. 5, pp. 583-589, 2015
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl